SG Americas Securities LLC Increases Stock Position in Masimo Corporation $MASI

Key Points

• SG Americas Securities LLC increased its Masimo stake by 84.2% in Q4, buying 7,510 shares to own 16,429 shares valued at $2,137,000.
• Other large moves included Viking Global starting a new ~ $129.1M position and Squarepoint Ops boosting holdings by 738.8% to 620,932 shares (~$91.6M), with Alyeska, Westfield and Bank of America also materially increasing stakes, leaving institutional investors with 85.96% ownership.
• Masimo has a market cap of $9.59B and a negative P/E (-16.94); analysts show a consensus Reduce rating with a $181.17 average target and mostly Hold reviews.

SG Americas Securities LLC grew its holdings in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 84.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,429 shares of the medical equipment provider's stock after buying an additional 7,510 shares during the period. SG Americas Securities LLC's holdings in Masimo were worth $2,137,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Viking Global Investors LP purchased a new position in Masimo during the 2nd quarter valued at about $129,096,000. Squarepoint Ops LLC grew its holdings in Masimo by 738.8% in the third quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider's stock worth $91,619,000 after purchasing an additional 546,905 shares during the period. Alyeska Investment Group L.P. increased its stake in shares of Masimo by 21.7% during the third quarter. Alyeska Investment Group L.P. now owns 1,381,085 shares of the medical equipment provider's stock valued at $203,779,000 after purchasing an additional 246,595 shares in the last quarter. Westfield Capital Management Co. LP increased its stake in shares of Masimo by 20.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,419,250 shares of the medical equipment provider's stock valued at $209,410,000 after purchasing an additional 238,047 shares in the last quarter. Finally, Bank of America Corp DE lifted its holdings in shares of Masimo by 113.0% during the third quarter. Bank of America Corp DE now owns 405,061 shares of the medical equipment provider's stock valued at $59,767,000 after purchasing an additional 214,885 shares during the last quarter. 85.96% of the stock is owned by hedge funds and other institutional investors.

Masimo Price Performance

Shares of NASDAQ MASI opened at $178.59 on Friday. The firm has a market cap of $9.59 billion, a P/E ratio of -16.94, a PEG ratio of 1.81 and a beta of 1.20. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $179.00. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72. The company has a 50 day moving average of $163.41 and a 200 day moving average of $149.45.

Analysts Set New Price Targets

Several analysts recently weighed in on MASI shares. Wells Fargo & Company upgraded Masimo to a "hold" rating in a research note on Wednesday, March 18th. Weiss Ratings reiterated a "sell (d)" rating on shares of Masimo in a research note on Thursday, January 22nd. Stifel Nicolaus set a $180.00 target price on Masimo in a report on Tuesday, February 17th. Piper Sandler downgraded Masimo from an "overweight" rating to a "hold" rating and set a $180.00 price target for the company. in a report on Tuesday, February 17th. Finally, Wolfe Research lowered Masimo from a "strong-buy" rating to a "hold" rating in a research report on Thursday, February 19th. Eight analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and a consensus target price of $181.17.

About Masimo

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.